A phase 1 and 2 clinical trial of Alimta (pemetrexed) in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer.
Phase of Trial: Phase I/II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Carboplatin; Pemetrexed
- Indications Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2010 Actual patient number (86) added as reported by ClinicalTrials.gov.
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.